Prompt Diagnostics
Developer of portable, cartridge-based molecular diagnostic platforms for point-of-care testing. Technologies include magnetofluidic cartridge sample processing (magnetic-bead plasma separation and nucleic acid extraction), rapid PCR and multiplexed assays, and automated cartridge-based serology. Devices are designed for battery-powered, field and clinic use with connectivity for clinical record integration. Work is supported by public grants and peer-reviewed publications.
Industries
Nr. of Employees
small (1-50)
Prompt Diagnostics
Products
Portable cartridge-based molecular diagnostic platform
An automated sample-to-answer platform combining magnetofluidic cartridge processing (plasma separation and nucleic acid extraction) with rapid PCR and on-board analysis in a battery-powered unit.
Automated serology cartridge (quantitative RPR integration)
Cartridge that combines two antibody-based tests, including quantitative Rapid Plasma Reagin (RPR), to provide automated serological diagnosis for syphilis in a point-of-care format.
Prompt Diagnostics Molecular Diagnostic Platform
A fully automated molecular diagnostic platform delivering PCR results in under 20 minutes with a compact cartridge and on-board analysis, designed for point-of-care use.
low-cost, automated platform integrating blood sample input, plasma separation, and HIV RNA extraction for HIV diagnostic testing
A platform based on Prompt’s magnetofluidic cartridge technology, using magnetic beads to separate plasma from blood and extract HIV RNA for diagnostic testing. It includes a prototype cartridge and a low-cost, battery-powered device to house it, designed for point-of-care HIV testing.
portable PCR platform to detect multiple pathogenic bacteria targets and their antibiotic susceptibility
A portable PCR platform under development by Prompt Diagnostics to detect multiple pathogenic bacteria targets and their antibiotic susceptibility, aimed at guiding treatment at the point-of-care.
automated, point-of-care diagnostic platform for infections caused by Treponema pallidum
An automated diagnostic platform combining two antibody-based tests, including quantitative Rapid Plasma Reagin (RPR), into a single automated cartridge for complete diagnosis within minutes in an affordable, easy-to-use format.
Portable cartridge-based molecular diagnostic platform
An automated sample-to-answer platform combining magnetofluidic cartridge processing (plasma separation and nucleic acid extraction) with rapid PCR and on-board analysis in a battery-powered unit.
Automated serology cartridge (quantitative RPR integration)
Cartridge that combines two antibody-based tests, including quantitative Rapid Plasma Reagin (RPR), to provide automated serological diagnosis for syphilis in a point-of-care format.
Prompt Diagnostics Molecular Diagnostic Platform
A fully automated molecular diagnostic platform delivering PCR results in under 20 minutes with a compact cartridge and on-board analysis, designed for point-of-care use.
low-cost, automated platform integrating blood sample input, plasma separation, and HIV RNA extraction for HIV diagnostic testing
A platform based on Prompt’s magnetofluidic cartridge technology, using magnetic beads to separate plasma from blood and extract HIV RNA for diagnostic testing. It includes a prototype cartridge and a low-cost, battery-powered device to house it, designed for point-of-care HIV testing.
portable PCR platform to detect multiple pathogenic bacteria targets and their antibiotic susceptibility
A portable PCR platform under development by Prompt Diagnostics to detect multiple pathogenic bacteria targets and their antibiotic susceptibility, aimed at guiding treatment at the point-of-care.
automated, point-of-care diagnostic platform for infections caused by Treponema pallidum
An automated diagnostic platform combining two antibody-based tests, including quantitative Rapid Plasma Reagin (RPR), into a single automated cartridge for complete diagnosis within minutes in an affordable, easy-to-use format.
Services
Design, prototyping, and analytical/clinical performance testing of portable cartridge-based diagnostic devices.
Development of multiplexed molecular and antibody-based assays integrated into automated cartridges.
Partnerships with public funders and incubators to translate lab research into point-of-care products.
Design, prototyping, and analytical/clinical performance testing of portable cartridge-based diagnostic devices.
Development of multiplexed molecular and antibody-based assays integrated into automated cartridges.
Partnerships with public funders and incubators to translate lab research into point-of-care products.
Expertise Areas
- Point-of-care molecular diagnostics
- Sample-to-answer cartridge development
- Magnetofluidic sample processing
- Rapid PCR and multiplexed assay development
Key Technologies
- Polymerase chain reaction (PCR)
- Magnetofluidic sample processing
- Magnetic bead-based nucleic acid extraction
- Droplet magnetofluidics
News & Updates
Grand Challenges grant to develop a low-cost automated platform integrating blood input, plasma separation, and HIV RNA extraction for HIV diagnostics; includes prototype cartridge and low-cost battery-powered device evaluation.
Phase II SBIR grant to develop an automated point-of-care diagnostic platform that combines antibody-based tests including quantitative RPR for syphilis.
CARB-X awarded funding to develop a portable PCR platform to detect pathogenic bacteria targets and antimicrobial susceptibility for point-of-care treatment guidance.
Announcement/coverage of NIH awards to advance technologies for HIV viral load detection including related efforts.
Company CEO interviewed and platform featured in industry article discussing funding and rapid PCR platform development.
Relocation to the LifeBridge Health BioIncubator located at Sinai Hospital in Baltimore, MD.
Grand Challenges grant to develop a low-cost automated platform integrating blood input, plasma separation, and HIV RNA extraction for HIV diagnostics; includes prototype cartridge and low-cost battery-powered device evaluation.
Phase II SBIR grant to develop an automated point-of-care diagnostic platform that combines antibody-based tests including quantitative RPR for syphilis.
CARB-X awarded funding to develop a portable PCR platform to detect pathogenic bacteria targets and antimicrobial susceptibility for point-of-care treatment guidance.
Announcement/coverage of NIH awards to advance technologies for HIV viral load detection including related efforts.
Company CEO interviewed and platform featured in industry article discussing funding and rapid PCR platform development.
Relocation to the LifeBridge Health BioIncubator located at Sinai Hospital in Baltimore, MD.